disorder
-
Sleep Health
Clinical Trial Finds Solriamfetol Significantly Improves Alertness and Performance for Early Morning Shift Workers Facing Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has revealed that solriamfetol, a wake-promoting medication currently used…
Read More » -
Sleep Health
A Neuroscientist Breaks Down a Common Misconception About a Rare Sleep Disorder
The complexities of neurological health often become obscured by popular media tropes, leading to widespread public misunderstanding of chronic conditions.…
Read More » -
Sleep Health
Clinical Trial Finds Solriamfetol Significantly Improves Alertness and Performance in Early Morning Shift Workers Suffering from Shift Work Disorder
The landscape of modern labor is increasingly defined by non-traditional hours, with approximately one-quarter of the global workforce operating outside…
Read More » -
Sleep Health
Clinical Trial at Mass General Brigham Reveals Solriamfetol Effectively Combats Fatigue in Early Morning Shift Workers with Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication currently used…
Read More » -
Sleep Health
Snoring Is Not Just a Symptom of OSA but May Actively Contribute to the Sleep Disorder
Researchers at Umeå University in Sweden have uncovered a groundbreaking biological mechanism that suggests snoring is not merely a benign…
Read More » -
Sleep Health
Solriamfetol Shows Promise in Enhancing Alertness and Safety for Early Morning Shift Workers Suffering from Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that the wake-promoting medication solriamfetol, marketed under…
Read More » -
Sleep Health
Study Suggests Snoring Is Not Just a Symptom of OSA but May Actively Contribute to the Sleep Disorder
For decades, the medical community has categorized snoring as a hallmark symptom of obstructive sleep apnea (OSA), a condition characterized…
Read More » -
Sleep Health
Solriamfetol Shows Promise in Improving Alertness for Early Morning Shift Workers Facing Shift Work Disorder
The landscape of modern labor is increasingly defined by non-traditional hours, with approximately 20% to 25% of the global workforce…
Read More » -
Sleep Health
Solriamfetol Shows Significant Promise in Treating Shift Work Disorder Among Early Morning Workers in New Clinical Trial
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication, significantly improves…
Read More » -
Sleep Health
NightWare Secures Strategic Series C Investment from Exit 156 Capital to Scale FDA-Cleared Digital Therapeutic for PTSD-Related Nightmare Disorder
NightWare Inc., a pioneer in the digital therapeutics sector, has entered into a strategic partnership with Exit 156 Capital, marking…
Read More »
